COMPARATIVE STUDY BETWEEN URINASTATIN AND NAFAMOSTAT MESYLATE FOR THE PREVENTION OF POST-ERCP PANCREATITIS

Autor:	Jungrae Lee, Sunjoon Park, HW Kim, Su-Ryun Kim, Dukjin Kang
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry Internal medicine medicine Urinastatin Post ercp pancreatitis business Gastroenterology Nafamostat mesylate
Zdroj:	ESGE Days.
ISSN:	1438-8812
DOI:	10.1055/s-0040-1704235
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4e292da2d9552d1337e7e520e4d887fe https://doi.org/10.1055/s-0040-1704235 Zobrazit plný text záznamu